900 related articles for article (PubMed ID: 19570580)
41. Synthesis, crystal structure and biological activities of a novel amidrazone derivative and its copper(II) complex--a potential antitumor drug.
Mazur L; Modzelewska-Banachiewicz B; Paprocka R; Zimecki M; Wawrzyniak UE; Kutkowska J; Ziółkowska G
J Inorg Biochem; 2012 Sep; 114():55-64. PubMed ID: 22694858
[TBL] [Abstract][Full Text] [Related]
42. Novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates from biologically active 1-aryl-2-hydrazinoimidazolines: synthesis, crystal structure and antiproliferative activity.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Dec; 41(12):1373-84. PubMed ID: 16996655
[TBL] [Abstract][Full Text] [Related]
43. Crystal structure and properties of the copper(II) complex of sodium monensin A.
Pantcheva IN; Dorkov P; Atanasov VN; Mitewa M; Shivachev BL; Nikolova RP; Mayer-Figge H; Sheldrick WS
J Inorg Biochem; 2009 Oct; 103(10):1419-24. PubMed ID: 19748125
[TBL] [Abstract][Full Text] [Related]
44. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, crystal structure, antibacterial assay and DNA binding activity of new binuclear Cu(II) complexes with bridging oxamidate.
Song YL; Li YT; Wu ZY
J Inorg Biochem; 2008 Sep; 102(9):1691-9. PubMed ID: 18538849
[TBL] [Abstract][Full Text] [Related]
46. Copper(II) complexes with tridentate pyrazole-based ligands: synthesis, characterization, DNA cleavage activity and cytotoxicity.
Gama S; Mendes F; Marques F; Santos IC; Carvalho MF; Correia I; Pessoa JC; Santos I; Paulo A
J Inorg Biochem; 2011 May; 105(5):637-44. PubMed ID: 21450266
[TBL] [Abstract][Full Text] [Related]
47. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
[TBL] [Abstract][Full Text] [Related]
48. Structural and electronic differences of copper(I) complexes with tris(pyrazolyl)methane and hydrotris(pyrazolyl)borate ligands.
Fujisawa K; Ono T; Ishikawa Y; Amir N; Miyashita Y; Okamoto K; Lehnert N
Inorg Chem; 2006 Feb; 45(4):1698-713. PubMed ID: 16471983
[TBL] [Abstract][Full Text] [Related]
49. The first iron(III) complexes with cyclin-dependent kinase inhibitors: Magnetic, spectroscopic (IR, ES+ MS, NMR, (57)Fe Mössbauer), theoretical, and biological activity studies.
Trávnícek Z; Popa I; Cajan M; Zboril R; Krystof V; Mikulík J
J Inorg Biochem; 2010 Apr; 104(4):405-17. PubMed ID: 20056279
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, antimicrobial and cytotoxicity study of 1,3-disubstituted-1H-naphtho[1,2-e][1,3]oxazines.
Verma V; Singh K; Kumar D; Klapötke TM; Stierstorfer J; Narasimhan B; Qazi AK; Hamid A; Jaglan S
Eur J Med Chem; 2012 Oct; 56():195-202. PubMed ID: 22982123
[TBL] [Abstract][Full Text] [Related]
51. Iron(III) complexes of tripodal monophenolate ligands as models for non-heme catechol dioxygenase enzymes: correlation of dioxygenase activity with ligand stereoelectronic properties.
Mayilmurugan R; Visvaganesan K; Suresh E; Palaniandavar M
Inorg Chem; 2009 Sep; 48(18):8771-83. PubMed ID: 19694480
[TBL] [Abstract][Full Text] [Related]
52. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and characterization of novel simultaneous C and O-coordinated and nitrate-bridged complexes of silver(I) with carbonyl-stabilized sulfonium ylides and their antibacterial activities.
Sabounchei SJ; Akhlaghi Bagherjeri F; Mozafari Z; Boskovic C; Gable RW; Karamian R; Asadbegy M
Dalton Trans; 2013 Feb; 42(7):2520-9. PubMed ID: 23212241
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and characterization of transition metal 2,6-pyridinedicarboxylic acid derivatives, interactions of Cu(II) and Ni(II) complexes with DNA in vitro.
Khan S; Nami SA; Siddiqi KS; Husain E; Naseem I
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Mar; 72(2):421-8. PubMed ID: 19046927
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, characterization, EXAFS investigation and antibacterial activities of new ruthenium(III) complexes containing tetradentate Schiff base.
Prabhakaran R; Geetha A; Thilagavathi M; Karvembu R; Krishnan V; Bertagnolli H; Natarajan K
J Inorg Biochem; 2004 Dec; 98(12):2131-40. PubMed ID: 15541503
[TBL] [Abstract][Full Text] [Related]
56. In vivo anticancer, anti-inflammatory, and toxicity studies of mixed-ligand Cu(II) complexes of dien and its Schiff dibases with heterocyclic aldehydes and 2-amino-2-thiazoline. Crystal structure of [Cu(dien)(Br)(2a-2tzn)](Br)(H(2)O).
Chaviara AT; Christidis PC; Papageorgiou A; Chrysogelou E; Hadjipavlou-Litina DJ; Bolos CA
J Inorg Biochem; 2005 Nov; 99(11):2102-9. PubMed ID: 16144711
[TBL] [Abstract][Full Text] [Related]
57. Tin(IV) cyanoximates: synthesis, characterization, and cytotoxicity.
Gerasimchuk N; Maher T; Durham P; Domasevitch KV; Wilking J; Mokhir A
Inorg Chem; 2007 Sep; 46(18):7268-84. PubMed ID: 17676728
[TBL] [Abstract][Full Text] [Related]
58. Structural and biological studies of mononuclear palladium(II) complexes containing N-substituted thiosemicarbazones.
Prabhakaran R; Renukadevi SV; Karvembu R; Huang R; Mautz J; Huttner G; Subashkumar R; Natarajan K
Eur J Med Chem; 2008 Feb; 43(2):268-73. PubMed ID: 17513020
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
Al-Saadi MS; Faidallah HM; Rostom SA
Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, characterization, molecular modeling and antimicrobial activity of 2-(2-(ethylcarbamothioyl)hydrazinyl)-2-oxo-N-phenylacetamide copper complexes.
El-Gammal OA
Spectrochim Acta A Mol Biomol Spectrosc; 2010 Feb; 75(2):533-42. PubMed ID: 20036192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
